Significantly lower incidence of early definite stent thrombosis of drug-eluting stents after unrestricted use in Japan using ticlopidine compared to western countries using clopidogrel: A retrospective comparison with western mega-studies

Journal of Cardiology

Volumn 54, Issue 2, 2009, Pages 238-244

  Ishikawa, Tetsuya ^a   Nakano, Yosuke ^a   Endoh, Akira ^a   Kubota, Takeyuki ^a   Suzuki, Teruhiko ^a   Nakata, Koutarou ^a   Miyamoto, Takashi ^a   Murakami, Michiaki ^a   Sakamoto, Hiroshi ^b   Imai, Kamon ^a   Mochizuki, Seibu ^b   Yoshimura, Michihiro ^b   Mutoh, Makoto ^a  

^a Saitama Prefecture Cardiovascular and Respiratory Center   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Drug eluting stent; Thienopyridine; Thrombosis

Indexed keywords

CLOPIDOGREL; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

ACUTE CORONARY SYNDROME; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; HEART INFARCTION; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; JAPAN; ST SEGMENT; ST SEGMENT ELEVATION; STENT THROMBOSIS;

ACUTE CORONARY SYNDROME; ANGINA, UNSTABLE; CLINICAL TRIALS AS TOPIC; DRUG-ELUTING STENTS; EUROPE; HUMANS; INCIDENCE; JAPAN; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; SIROLIMUS; THROMBOSIS; TICLOPIDINE; UNITED STATES;

EID: 70349267535     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.05.013     Document Type: Article

References (38)

1. Kimura T., Morimoto T., Nakagawa Y., Tamura T., Kadota K., Yasumoto H., Nishikawa H., Hiasa Y., Muramatsu T., Meguro T., Inoue N., Honda H., Hayashi Y., Miyazaki S., Oshima S., et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 119 (2009) 987-995
2. Mutoh M., Ishikawa T., Hasuda T., Okada H., Endo A., Miyanaga S., Higashitani M., Nakano Y., Kubota T., Nakata K., Nagoshi T., Hayashi M., Sakamoto H., Oota M., Imai K., et al. Predictors of target lesion revascularization and documented stent thrombosis beyond 30 days after sirolimus-eluting stent implantation: retrospective analysis in consecutive 1070 angiographic follow-up lesions. Circ J 71 (2007) 1328-1331
3. United States Food and Drug Administration (FDA) Clinical Overview for Panel Packet; DES thrombosis panel 1-32, December 7-8, 2006.
4. de la Torre-Hernández J.M., Alfonso F., Hernández F., Elizaga J., Sanmartin M., Pinar E., Lozano I., Vazquez J.M., Botas J., de Prado A.P., Hernández J.M., Sanchis J., Nodar J.M., Gomez-Jaume A., Larman M., et al. Drug-eluting stent thrombosis. Results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). J Am Coll Cardiol 51 (2008) 986-990
5. Ong A.T., Hoye A., Aoki J., van Mieghem C.A., Rodriguez Granillo G.A., Sonnenschein K., Regar E., McFadden E.P., Sianos G., van der Giessen W.J., de Jaegere P.P., de Feyter P., van Domburg R.T., and Serruys P.W. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 45 (2005) 947-953
6. Pinto Slottow T.L., Steinberg D.H., Roy P.K., Buch A.N., Okabe T., Xue Z., Kaneshige K., Torguson R., Lindsay J., Pichard A.D., Satler L.F., Suddath W.O., Kent K.M., and Waksman R. Observations and outcomes of definite and probable drug-eluting stent thrombosis seen at a single hospital in a four-year period. Am J Cardiol 102 (2008) 298-303
7. Stettler C., Wandel S., Allemann S., Kastrati A., Morice M.C., Schömig A., Pfisterer M.E., Stone G.W., Leon M.B., de Lezo J.S., Goy J.J., Park S.J., Sabaté M., Suttorp M.J., Kelbaek H., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370 (2007) 937-948
8. Aoki J., Lansky A.J., Mehran R., Moses J., Bertrand M.E., McLaurin B.T., Cox D.A., Lincoff A.M., Ohman E.M., White H.D., Parise H., Leon M.B., and Stone G.W. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial. Circulation 119 (2009) 687-698
9. Ishikawa T., Mutoh M., Fuda Y., Sakamoto H., Okada H., Higashitani M., Nakano Y., Yamaguchi J., Enta K., Satoh T., Imai K., Horie T., and Mochizuki S. Circ J 70 (2006) 1091-1092
10. Sakamoto H., Ishikawa T., Mutoh M., Imai K., and Mochizuki S. Angiographic and clinical outcomes after sirolimus-eluting stent implantation to de novo ostial lesion of the right coronary artery: a retrospective study. Circ J 72 (2008) 880-885
11. Fujii K., Carlier S.G., Mintz G.S., Yang Y.M., Moussa I., Weisz G., Dangas G., Mehran R., Lansky A.J., Kreps E.M., Collins M., Stone G.W., Moses J.W., and Leon M.B. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 45 (2005) 995-998
12. Cheneau E., Satler L.F., Escolar E., Suddath W.O., Kent K.M., Weissman N.J., Waksman R., and Pichard A.D. Underexpansion of sirolimus-eluting stents: incidence and relationship to delivery pressure. Catheter Cardiovasc Interv 65 (2005) 222-226
13. Hong M.K., Mintz G.S., Lee C.W., Park D.W., Choi B.R., Park K.H., Kim Y.H., Cheong S.S., Song J.K., Kim J.J., Park S.W., and Park S.J. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 1305-1310
14. Sonoda S., Morino Y., Ako J., Terashima M., Hassan A.H., Bonneau H.N., Leon M.B., Moses J.W., Yock P.G., Honda Y., Kuntz R.E., Fitzgerald P.J., and SIRIUS Investigators. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 43 (2004) 1959-1963
15. Taguchi I., Kanaya T., Toi T., Abe S., Sugimura H., Hoshi T., Oida A., Araki H., Ogawa K., and Kaneko N. Comparison of the effects of a distal embolic protection device and an aspiration catheter during percutaneous coronary intervention in patients with acute myocardial infarction. Circ J 69 (2005) 49-54
16. Grines C.L., Bonow R.O., Casey D.E., Gardner T.J., Lockhart P.B., Moliterno D.J., O'Gara P., Whitlow P., and American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 115 (2007) 813-818
17. Honda Y., and Fitzgerald P.J. Stent thrombosis. An issue revised in a changing world. Circulation 108 (2003) 2-5
18. Moreno R., Fernández C., Hernández R., Alfonso F., Angiolillo D.J., Sabaté M., Escaned J., Bañuelos C., Fernández-Ortiz A., and Macaya C. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 45 (2005) 954-959
19. Roy P., Torguson R., Okabe T., Pinto Slottow T.L., Steinberg D.H., Xue Z., Satler L.F., Pichard A.D., and Waksman R. Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents. J Interv Cardiol 20 (2007) 307-313
20. Roy P., Steinberg D.H., Sushinsky S.J., Okabe T., Pinto Slottow T.L., Kaneshige K., Xue Z., Satler L.F., Kent K.M., Suddath W.O., Pichard A.D., Weissman N.J., Lindsay J., and Waksman R. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 29 (2008) 1851-1857
21. Kimura T., and Mitsudo K. Advance in coronary intervention: impact of DES from j-CYPHER registry. Nihon Naikagakkaishi 96 (2007) 254-261 (in Japanese)
22. Sianos G., Papafaklis M.I., Daemen J., Vaina S., van Mieghem C.A., van Domburg R.T., Michalis L.K., and Serruys P.W. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol 50 (2007) 573-583
23. Ge L., Airoldi F., Iakovou I., Cosgrave J., Michev I., Sangiorgi G.M., Montorfano M., Chieffo A., Carlino M., Corvaja N., and Colombo A. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: importance of final kissing balloon post-dilation. J Am Coll Cardiol 46 (2005) 613-620
24. Saia F., Lemos P.A., Lee C.H., Arampatzis C.A., Hoye A., Degertekin M., Tanabe K., Sianos G., Smits P.C., McFadden E., Hofma S.H., van der Giessen W.J., de Feyter P.J., van Domburg R.T., and Serruys P.W. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study. Circulation 108 (2003) 1927-1929
25. Lemos P.A., Serruys P.W., van Domburg R.T., Saia F., Arampatzis C.A., Hoye A., Degertekin M., Tanabe K., Daemen J., Liu T.K., McFadden E., Sianos G., Hofma S.H., Smits P.C., van der Giessen W.J., et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry. Circulation 109 (2004) 190-195
26. Spaulding C., Henry P., Teiger E., Beatt K., Bramucci E., Carrié D., Slama M.S., Merkely B., Erglis A., Margheri M., Varenne O., Cebrian A., Stoll H.P., Snead D.B., Bode C., and TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 355 (2006) 1093-1104
27. Kastrati A., Dibra A., Spaulding C., Laarman G.J., Menichelli M., Valgimigli M., Di Lorenzo E., Kaiser C., Tierala I., Mehilli J., Seyfarth M., Varenne O., Dirksen M.T., Percoco G., Varricchio A., et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 28 (2007) 2706-2713
28. Colombo A., and Chieffo A. Drug-eluting stent update 2007. Part III. Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation 116 (2007) 1424-1432
29. Ishikawa T., Mochizuki S., Yoshimura M., Imai K., and Mutoh M. Angiographic outcome after primary stenting to ST-segment elevation acute myocardial infarction with sirolimus- versus paclitaxel-eluting stents. Circ J 73 Suppl 1 (2009) 643
30. Fujimoto H., Tao S., Masuda J., Mitani H., Ito S., Fujimoto Y., Maehara A., Ishiwata S., Yamaguchi T., and Ohno M. The efficacy of bare metal stent implantation for patients with acute myocardial infarction in the drug-eluting stent era. J Cardiol 51 (2008) 189-195
31. Sawada T., Shite J., Shinke T., Tanino Y., Ogasawara D., Kawamori H., Kato H., Miyoshi N., Yoshino N., and Hirata K. Very late thrombosis of sirolimus-eluting stent due to late malapposition: serial observations with optical coherence tomography. J Cardiol 52 (2008) 290-295
32. Lee S.W., Park S.W., Hong M.K., Kim Y.H., Lee B.K., Song J.M., Han K.H., Lee C.W., Kang D.H., Song J.K., Kim J.J., and Park S.J. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol 46 (2005) 1833-1837
33. Wiviott S.D., Braunwald E., McCabe C.H., Horvath I., Keltai M., Herrman J.P., Van de Werf F., Downey W.E., Scirica B.M., Murphy S.A., Antman E.M., and TRITON-TIMI 38 Investigators. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 371 (2008) 1353-1363
34. Price M.J., Endemann S., Gollapudi R.R., Valencia R., Stinis C.T., Levisay J.P., Ernst A., Sawhney N.S., Schatz R.A., and Teirstein P.S. Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 29 (2008) 992-1000
35. De Luca G., Suryapranata H., Stone G.W., Antoniucci D., Tcheng J.E., Neumann F.J., Van de Werf F., Antman E.M., and Topol E.J. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293 (2005) 1759-1765
36. Steigen T.K., Maeng M., Wiseth R., Erglis A., Kumsars I., Narbute I., Gunnes P., Mannsverk J., Meyerdierks O., Rotevatn S., Niemelä M., Kervinen K., Jensen J.S., Galløe A., Nikus K., et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions. The Nordic bifurcation study. Circulation 114 (2006) 1955-1961
37. Weerakkody G.J., Jakubowski J.A., Brandt J.T., Payne C.D., Naganuma H., and Winters K.J. Greater inhibition of platelet aggregation and reduced response variability with prasugrel versus clopidogrel: an integrated analysis. J Cardiovasc Pharmacol Ther 12 (2007) 205-212
38. Okabe T., Mintz G.S., Buch A.N., Roy P., Hong Y.J., Smith K.A., Torguson R., Gevorkian N., Xue Z., Satler L.F., Kent K.M., Pichard A.D., Weissman N.J., and Waksman R. Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol 100 (2007) 615-620